This study investigates the extent of cardiac comorbidities and complications among hospitalized patients with COVID-19.

Cardiovascular complications are frequent among COVID-19 patients, and might contribute to adverse clinical events and mortality, together with pre-existing cardiovascular comorbidities and RF. Clinicians worldwide should be aware of this association, to identifying patients at higher risk.

Among 77,317 hospitalized patients from 21 studies, 12.86% had cardiovascular comorbidities or RF.

Cardiovascular complications were registered in 14.09% of cases during hospitalization.

At meta-regression analysis, pre-existing cardiovascular comorbidities or RF were significantly associated to cardiovascular complications in COVID-19 patients.

Read More